Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Defying Genetic Destiny: The Man Whose Brain Resisted Early-Onset Alzheimer’s
Australia Is Latest Country to Say ‘No’ to Leqembi
Could a Chronic Gut Infection Trigger Alzheimer’s?
Do Statins Cause Dementia? Here’s What the Science Actually Says
Rising Microplastic Levels in the Brain: A Growing Concern
High-tech Headsets to Combat Alzheimer’s
TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2025.01)
‘Unsettling:’ Federal DEI Ban a ‘Step Backward’ for Alzheimer’s Trials
‘Mission Critical’: Why the FDA Approved an Alzheimer’s Drug Update During Comms Freeze
Feeling Lonely Linked to Higher Risk of Dementia in Older Adults
Leqembi Vs. Kisunla: An Alzheimer’s Drug Point-by-Point Comparison
NIH Activities Grind to Halt Under Trump Comms Freeze
Some Trial Volunteers Had Higher Risk of Brain Bleeds. Here’s Why Drugmakers Didn’t Tell Them
Axsome Asks FDA to Approve Questionable Alzheimer’s Agitation Drug
How a Condition Transmitted by Cannibalism Shed New Light on Brain Diseases
Previous
8
9
10
Next
Page load link
Go to Top